{"id":908038,"date":"2025-11-10T20:21:02","date_gmt":"2025-11-11T01:21:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/"},"modified":"2025-11-10T20:21:02","modified_gmt":"2025-11-11T01:21:02","slug":"electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","title":{"rendered":"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p>ROCKAWAY, N.J., Nov.  10, 2025  (GLOBE NEWSWIRE) &#8212; electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the\u00a0<strong>Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum. <\/strong>The conference will take place in New York on Thursday, November 20, 2025 at The Westin NY Grand Central Hotel.<\/p>\n<p>Management will host one-on-one meetings throughout the day.<\/p>\n<p>Investors who wish to request a meeting should contact their sales representative at Canaccord Genuity or reach out to electroCore Investor Relations at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vet8WTYtqJ4o8I_gs16Sl9eG7Rc-l3-XENK9s284q0SpCPUWdokP5NhzKrcWyCXujuoJM4-OQ2_BkomXjU4UHQ==\" rel=\"nofollow\" target=\"_blank\">ecor@fnkir.com<\/a>.<\/p>\n<p>\n        <strong>About electroCore, Inc.<\/strong>\n      <\/p>\n<p>electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company\u2019s two leading prescription products to treat chronic pain syndromes through non-invasive neuromodulation technology are gammaCore non-invasive vagus nerve stimulation, or nVNS, and the Quell<sup>\u00ae<\/sup>\u00a0Fibromyalgia. Additionally, the Company commercializes its handheld and personal use Truvaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.<\/p>\n<p>For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ETtmEz-tM9TIdDdrS9Ovv-DG7RMRxDOhRzcQY_2Rakoa4H2Y5k9UZWBRvl9me0Q6IdwEOrUDy4ofznZjvtbvzg3htTwIU6nd18cGM8aQrlg=\" rel=\"nofollow\" target=\"_blank\">www.electrocore.com<\/a>.<\/p>\n<p>\n        <strong>Contact<\/strong>\n      <\/p>\n<p>ECOR Investor Relations<br \/>(973) 302-9253<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B0Ue_7kVcvpOJRaFZV-XMcHXvk7K_XF9mPYT7ZGO11bqxcPK_LqbEPOBIPslTGtmogOe6dwcS6SYT9qAHCz03DfHRTn6xqaj07yFrzTSW6Gvz3AT75-eKU4eYJvsRDUK\" rel=\"nofollow\" target=\"_blank\">investors@electrocore.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NGViNTRjYjYtMjQ4NS00ZmRhLWIxZGItODgyM2M3YWJhOWQ0LTExMTAzMTUtMjAyNS0xMS0xMC1lbg==\/tiny\/electroCore-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROCKAWAY, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) &#8212; electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the\u00a0Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum. The conference will take place in New York on Thursday, November 20, 2025 at The Westin NY Grand Central Hotel. Management will host one-on-one meetings throughout the day. Investors who wish to request a meeting should contact their sales representative at Canaccord Genuity or reach out to electroCore Investor Relations at ecor@fnkir.com. About electroCore, Inc. electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company\u2019s two leading prescription products to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-908038","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCKAWAY, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) &#8212; electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the\u00a0Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum. The conference will take place in New York on Thursday, November 20, 2025 at The Westin NY Grand Central Hotel. Management will host one-on-one meetings throughout the day. Investors who wish to request a meeting should contact their sales representative at Canaccord Genuity or reach out to electroCore Investor Relations at ecor@fnkir.com. About electroCore, Inc. electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company\u2019s two leading prescription products to &hellip; Continue reading &quot;electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-11T01:21:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum\",\"datePublished\":\"2025-11-11T01:21:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/\"},\"wordCount\":195,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/\",\"name\":\"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ=\",\"datePublished\":\"2025-11-11T01:21:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","og_locale":"en_US","og_type":"article","og_title":"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk","og_description":"ROCKAWAY, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) &#8212; electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the\u00a0Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum. The conference will take place in New York on Thursday, November 20, 2025 at The Westin NY Grand Central Hotel. Management will host one-on-one meetings throughout the day. Investors who wish to request a meeting should contact their sales representative at Canaccord Genuity or reach out to electroCore Investor Relations at ecor@fnkir.com. About electroCore, Inc. electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company\u2019s two leading prescription products to &hellip; Continue reading \"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-11T01:21:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum","datePublished":"2025-11-11T01:21:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/"},"wordCount":195,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","name":"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ=","datePublished":"2025-11-11T01:21:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MjcwOSM3MjU1Njg5IzIwOTg3NDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/908038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=908038"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/908038\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=908038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=908038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=908038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}